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Abstract 
Pain-related anxiety has been positively associated with tobacco dependence, smoking motives, 
self-reported barriers to smoking cessation, and expectancies for negative affect reduction via 
smoking. Although emerging research suggests that pain-related anxiety may play a role in the 
maintenance of tobacco dependence, no previous work has examined pain-related anxiety as a 
predictor of smoking cessation outcomes. The goal of the current study was to test the hypothesis 
that pain-related anxiety would predict early lapse and relapse to cigarette smoking among a 
sample of 55 daily tobacco smokers who participated in an unaided cessation attempt (i.e., 
without psychosocial or pharmacological intervention). Pain-related anxiety was assessed at 
baseline using the PASS-20, which yields a total score that ranges from 0-100. Number of days 
to early lapse (i.e., any instance of smoking during the first 14 days post-quit) and early relapse 
(i.e., 7 consecutive days of smoking that began during the first 28 days post-quit) were assessed 
using timeline follow-back procedures. Cox regression analyses indicated that pain-related 
anxiety was a significant predictor of both early smoking lapse and relapse, such that for every 
one point increase on the PASS-20, the risk of early lapse increased by 3.7% and the risk of early 
relapse increased by 3.6%. These effects were evident above and beyond the variance accounted 
for by tobacco dependence, past four-week pain severity, anxiety sensitivity, and the presence of 
current Axis I psychopathology. Kaplan-Meier survival analyses further revealed that among 
early lapsers, greater pain-related anxiety predicted a more rapid trajectory to lapse. Pain-related 
anxiety was also shown to be a significant predictor of early lapse when the sample was limited 
to smokers who endorsed past four-week pain. These findings lend support to the notion that 
pain-related anxiety may contribute to the maintenance of tobacco dependence among smokers 
who experience varying levels of pain intensity.   
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Pain-Related Anxiety as a Predictor of Early Lapse and Relapse to Cigarette Smoking 
Cigarette smoking remains the leading cause of preventable death worldwide (World 
Health Organization, 2008). Despite known health risks and an annual economic burden in 
excess of $300 billion in the United States, about 42 million Americans continue to smoke 
tobacco cigarettes (US Department of Health & Human Services, 2014). Although about half of 
all smokers attempt to quit each year, nearly 70% do not utilize recommended pharmacological 
or behavioral cessation aids (e.g., nicotine replacement, cognitive-behavioral counseling; CDC, 
2011), and the vast majority (72-85%) who engage in an unaided quit attempt relapse within the 
first month (Hughes, Keely, & Naud, 2004). Whereas substantial progress has been made in the 
identification of reliable predictors of smoking cessation (e.g., nicotine dependence, withdrawal 
symptoms, self-efficacy for quitting; Ditre, Zale, & Brandon, 2015), additional work is needed to 
identify risk factors that can be addressed in the context of tailored interventions. 
There is increasing empirical and clinical interest in the role of pain and related factors in 
the maintenance of tobacco dependence (e.g., Ditre, Heckman, Butts, & Brandon, 2010; Ditre, 
Langdon, Kosiba, Zale, & Zvolensky, 2015). Pain has been defined as “an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage or defined in terms of 
such damage” (IASP, 1994), and pain complaints account for up to 80% of all annual U.S. 
physician visits (Mayo Clinic, 2001; Turk & Melzack, 1992). Although about 18% of U.S. adults 
smoke cigarettes, rates of smoking among persons in pain appear to be substantially higher. 
Indeed, an estimated 30-42% of persons with pain concurrently smoke tobacco cigarettes 
(Zvolensky, McMillan, Gonzalez, & Asmundson, 2009), and the prevalence of smoking among 
clinical pain patients may be as high as 68% (Michna et al., 2004). 
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A recently proposed reciprocal model suggests that smoking and pain interact in the 
manner of a positive feedback loop, resulting in greater pain and the maintenance of tobacco 
dependence (Ditre, Brandon, Zale, & Meagher, 2011b). Consistent with this perspective, 
cigarette smoking has been identified as a unique risk factor in the onset and progression of 
painful conditions (e.g., Aho & Heliovaara, 2004; Shiri, Karppinen, Leino-Arjas, Solovieva, & 
Viikari-Juntura, 2010), situational pain has been shown to motivate smoking urge and behavior 
(e.g., Ditre & Brandon, 2008), and pain patients have reliably endorsed smoking cigarettes to 
cope with pain (e.g., Jamison, Stetson, & Parris, 1991; Patterson et al., 2012).  
To better inform the development of tailored interventions, researchers have recently 
turned their attention to the identification of anxiety-relevant transdiagnostic factors in the 
etiology, progression, and maintenance of both pain and smoking (Zale, Maisto, & Ditre, 2015). 
Indeed, various facets of anxiety (e.g., generalized anxiety, anxiety sensitivity) have been 
associated with greater pain and the maintenance of tobacco dependence (e.g., Assayag, 
Bernstein, Zvolensky, Steeves, & Stewart, 2012; Leventhal & Zvolensky, 2015; McCracken & 
Keogh, 2009). One factor that is of increasing clinical and empirical interest is the cognitive-
affective construct termed pain-related anxiety (e.g., Ditre, Langdon, et al., 2015; Ditre, Zale, 
Kosiba, & Zvolensky, 2013). Pain-related anxiety reflects the tendency to respond to pain or 
pain-related events with anxiety or fear (McCracken, Zayfert, & Gross, 1992), and may be 
particularly important to understanding the maintenance and exacerbation of tobacco dependence 
due to its specificity to pain-related phenomena and incorporation of pain-relevant behavioral 
responses (i.e., responding with escape or avoidance). Pain-related anxiety has been identified as 
a risk factor in the transition from acute to chronic pain (Boersma & Linton, 2006; Vlaeyen & 
Linton, 2000), and greater pain-related anxiety has been related to greater pain intensity, 
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maladaptive approaches to pain coping, and increased somatic reactivity in anticipation of pain-
eliciting physical activity (McCracken, Gross, Sorg, & Edmands, 1993). A growing body of 
evidence further suggests that pain-related anxiety can be experienced even in the absence of co-
occurring pain (e.g., Abrams, Carleton, & Asmundson, 2007).  
Pain-related anxiety has also been implicated in the maintenance of substance use in 
general (e.g., Hogan, Gonzalez, Howell, Bonn-Miller, & Zvolensky, 2010), and tobacco smoking 
in particular. Among individuals with chronic pain, higher levels of pain-related anxiety have 
been associated with current smoking (vs. non-smoking; Hooten et al., 2009; Hsu, Harden, & 
Houle, 2002) and the use of tobacco to cope with pain (Patterson et al., 2012). Pain-related 
anxiety has also been positively associated with both primary (i.e., central features of tobacco 
dependence, such as compulsion to smoke) and secondary (i.e., situational motivators of 
smoking, such as mood regulation) smoking dependence motives among smokers with chronic 
pain (Ditre et al., 2013), and those recruited from the local community (Ditre, Langdon, et al., 
2015). Among community samples, pain-related anxiety has been positively associated with self-
reported barriers to smoking cessation and expectations that smoking can alleviate negative 
mood (Ditre, Langdon, et al., 2015; Gonzalez, Hogan, McLeish, & Zvolensky, 2010). 
Collectively, these data suggest that pain-related anxiety should be considered in the 
maintenance of tobacco dependence among smokers with and without co-occurring pain. 
 An important next step in this line of research is to assess the extent to which pain-related 
anxiety may be associated with smoking cessation outcomes. The primary goal of the current 
study was to test whether pain-related anxiety would predict early cessation outcomes among a 
sample of daily tobacco smokers who were recruited from the local community to participate in a 
self-guided smoking cessation attempt (i.e., without psychosocial or pharmacological 
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intervention). Given evidence that pain-related anxiety may be particularly important among 
smokers with co-occurring pain (e.g., Ditre et al., 2013; Hooten et al., 2009), a secondary goal of 
this study was to examine the relationship between pain-related anxiety and cessation outcomes 
among a subsample of participants who endorsed past four-week pain. Specifically, we 
hypothesized that higher levels of pain-related anxiety would be associated with (a) an increased 
risk of early lapse (i.e., a lapse within 14 days post-quit) and early relapse (i.e., a relapse 
beginning within 28 days post-quit) to smoking, and (b) a more rapid trajectory to lapse among 
early-lapsers and to relapse among early-relapsers. Early abstinence outcomes were of particular 
interest given that participants engaged in an unaided quit attempt, and that duration of 
abstinence prior to the first lapse/relapse (e.g., < 1 month) is highly predictive of longer-term 
cessation outcomes (e.g., 6-12 months; Brown et al., 2001).  
Method 
Participants 
 Participants were recruited from the local community at two sites (Houston, TX and 
Burlington, VT) via advertisements for a smoking cessation study that consisted of a self-guided 
quit attempt (Langdon, Farris, Øverup, & Zvolensky, 2015). Participants were screened for the 
following inclusion criteria: between 18 and 65 years of age, smoke at least 8 cigarettes per day 
for at least one year (verified via expired carbon monoxide [CO] breath analysis; ≥ 8 ppm), have 
not decreased the number of daily cigarettes smoked by more than half in the past 6 months, and 
willing to engage in a self-guided quit attempt. Participants were also screened for the following 
exclusion criteria: current use of nicotine replacement or other tobacco products, current 
substance dependence (excluding nicotine dependence), current or past history of psychotic 
spectrum symptoms or disorders, and current use of psychotropic medication.  
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             A total of 122 participants attended a baseline session, and 80 were deemed eligible to 
participate in the self-guided quit attempt and completed the measure of pain-related anxiety. Of 
these, 55 participants (69%) attended their quit day appointment and were included in the current 
analyses (see Figure 1)1. It is important to note that modest retention rates are expected in studies 
that ask daily tobacco smokers to engage in an unaided, non-incentivized quit attempt. For 
example, in a previous study that required a self-guided quit attempt, approximately 23% of the 
sample withdrew prior to the quit day (Zvolensky et al., 2008).  
Measures 
Pain-related anxiety. Pain-related anxiety was assessed using the Pain Anxiety 
Symptom Scale-20 item (PASS-20; McCracken & Dhingra, 2002). The PASS-20 uses a 6-point 
Likert scale ranging from never (0) to always (5) to assess how often participants engage in 
various thoughts (e.g., “When I feel pain, I am afraid that something terrible will happen”) and 
behaviors (e.g., “I avoid important activities when I hurt”). PASS-20 total scores (range 0-100) 
have demonstrated utility as a both a continuous variable with higher scores reflecting greater 
pain-related anxiety (i.e., occurring along a latent continuum ranging from low to high; 
Asmundson, Collimore, Bernstein, Zvolensky, & Hadjistavropoulos, 2007), and as a taxonic 
variable for classifying individuals as either low or high (e.g., Evans, Seidman, Lung, Zeltzer, & 
Tsao, 2013). The PASS-20 has demonstrated excellent reliability and validity in a previous study 
of adults who did not report a history of chronic pain or endorse severe current pain (α = .91; 
Abrams et al., 2007), thus supporting its utility among samples that were not recruited based on 
pain status. The PASS-20 demonstrated excellent internal consistency in the current sample (α = 
.91), and the statistical distribution of total scores fell within the normal ranges suggested by 
Kim et al. (2013), with a skewness of 0.531 (SE = 0.322) and kurtosis of 0.104 (SE = 0.634). 
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Past Four-Week Pain Severity. The Short Form Health Survey-12 (SFHS; Ware, 
Kosinski, & Keller, 1996) is a widely used 12-item self-report measure of mental and physical 
health. Consistent with previous research (e.g., Ditre, Langdon, et al., 2015), a single item was 
used to assess the presence of past four-week bodily pain  (i.e., “How much bodily pain have you 
had during the past four weeks?”; Ware et al., 1996). Response options consisted of none, very 
mild, mild, moderate, and severe. Given demonstrated associations between the presence of pain 
and numerous smoking-related factors and outcomes (e.g., Ditre, Brandon, Zale, & Meagher, 
2011a; Zvolensky, McMillan, et al., 2009), past four-week bodily pain severity was selected as 
an a priori covariate for all statistical analyses.   
Tobacco use and dependence. Historical and current tobacco use (e.g., number of 
cigarettes smoked per day) were assessed via self-report. Tobacco dependence was assessed 
using the Heaviness of Smoking Index (HSI; Heatherton, Kozlowski, Frecker, Rickert, & 
Robinson, 1989), which is comprised of two items (i.e., “How soon after you wake up do you 
smoke your first cigarette?” and “How many cigarettes per day do you smoke?”; Heatherton et 
al., 1989). HSI scores were identified as an a priori covariate, given that they have been shown to 
predict smoking abstinence outcomes (Courvoisier & Etter, 2010), especially during the early 
stages (i.e., 1 week to 1 month) of a cessation attempt (Yong et al., 2014).  
Current Axis I Psychopathology. All participants were administered the Structured 
Clinical Interview for DSM-IV-TR Axis I Disorders, Non-Patient Edition (SCID-IV-N/P) by a 
trained clinician to assess whether participants met criteria for past-month Axis I 
psychopathology. Interviews were audio-taped, the reliability of a random selection of 10% of 
interviews was checked for accuracy, and there were no diagnostic disagreements between the 
SCID interviewer and outsider raters. Consistent with previous work, a single dichotomous 
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variable was created to reflect the presence (1) or absence (0) of current Axis I psychopathology 
(e.g., Johnson, Farris, Schmidt, Smits, & Zvolensky, 2013). Given established associations 
between the presence of Axis I psychopathology and greater difficulty quitting (e.g., Lasser et 
al., 2000; Weinberger, Pilver, Desai, Mazure, & McKee, 2013; Weinberger, Pilver, Hoff, 
Mazure, & McKee, 2013; Zvolensky et al., 2008), this variable was identified as an a priori 
covariate.  
Anxiety Sensitivity. The Anxiety Sensitivity Index-III is a well-established, 18-item 
measure of the fear that arousal-related sensations may result in adverse consequences such as 
death, insanity, or social rejection (ASI-3; Taylor et al., 2007). Given that anxiety sensitivity has 
been positively associated with affect-regulatory smoking motives (Farris, Leventhal, Schmidt, 
& Zvolensky, 2015), more severe nicotine withdrawal (e.g., Johnson, Stewart, Rosenfield, 
Steeves, & Zvolensky, 2012), and increased risk for lapse and relapse (Assayag et al., 2012; 
Zvolensky, Stewart, Vujanovic, Gavric, & Steeves, 2009), ASI-3 scores were selected as an a 
priori covariate. The ASI-3 demonstrated excellent internal consistency in the current sample (α 
= .93).  
Time to Lapse/Relapse. Time to lapse and relapse were assessed via timeline follow-
back procedures. The timeline follow-back is a widely used, interview-style assessment that 
incorporates calendar-guided recall and anchoring of dates to significant events (Sobell & Sobell, 
1992). Timeline follow-back procedures for cigarette smoking have demonstrated high reliability 
and validity (as measured by correlations with daily monitored smoking, reports from significant 
others, and saliva cotinine levels; Brown et al., 1998). Participants were asked to recall and 
record the total number of cigarettes smoked each day prior to the follow-up session. Consistent 
with previous research, a lapse (i.e., any instance of smoking after a quit attempt) during the first 
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14 days post-quit was classified as an ‘early lapse’ (e.g., Brown et al., 2008; Holt, Litt, & 
Cooney, 2012; Zvolensky, Stewart, et al., 2009), and a relapse (i.e., 7 consecutive days of 
smoking following a quit attempt) beginning during the first 28 days post-quit was classified as 
an ‘early relapse’ (e.g., al'Absi, Hatsukami, & Davis, 2005; Nakajima & al'Absi, 2011). These 
classifications were also employed because they tend to capture the majority of early 
lapses/relapses and have demonstrated utility in predicting longer-term abstinence rates (e.g., 
Brown et al., 2001; Brown et al., 2009).  
Procedure 
  Participants were recruited to take part in a larger study examining barriers to successful 
smoking cessation (Langdon et al., 2015). Upon arrival to the baseline session, smoking status 
was biochemically verified by expired CO, the SCID-IV/NP was administered, and self-report 
questionnaires were completed. Participants were compensated $20 for completion of the 
baseline session. Eligible respondents were then invited to participate in an unaided smoking 
cessation attempt. Each participant selected his/her own quit date, which typically occurred 
within two weeks of the baseline assessment (M = 12.8 days, SD = 5.7). In-person follow-up 
appointments were scheduled for the quit day, and days 3, 7, 14, 28, and 90 post-quit. Each 
follow-up visit consisted of self-report assessments and timeline follow-back procedures. 
Participants were compensated $10 for completing each follow-up assessment, and could earn an 
additional $20 for completing all of them. Participants were not incentivized to remain abstinent. 
Procedural details are depicted in Figure 2. 
Data Analytic Plan 
 All analyses were conducted using SPSS Statistics 21 (IBM SPSS Statistics, 2012). First, 
we ran a series of bivariate correlations to test zero-order associations between PASS-20 total 
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scores (pain-related anxiety), number of days to lapse and relapse, HSI scores (tobacco 
dependence), severity of past four-week bodily pain, presence of current Axis I 
psychopathology, ASI-3 scores (anxiety sensitivity), and sociodemographic factors.  
            Next, we used the Cox proportional hazards model to estimate the risk of both early lapse 
and early relapse as a function of pain-related anxiety. The Cox model is a well-established 
statistical procedure that has frequently been used to examine predictors of lapse/relapse to 
cigarette smoking (e.g., Lemieux, Nakajima, Hatsukami, Allen, & al’Absi, 2015; Messer et al., 
2015; Nakajima & al'Absi, 2011; Schepis, Tapscott, & Krishnan-Sarin, 2016; Zvolensky et al., 
2008). This semiparametric model estimates hazard ratios by examining the pattern of 
covariation of predictor variables with the event of interest (e.g., lapse/relapse; Christensen, 
1987; Cox & Oakes, 1984). Unlike ordinary regression models, the Cox proportional hazards 
model incorporates information from both censored (cases are ‘censored’ if the exact survival 
time is unknown; Christensen, 1987) and uncensored observations when estimating model 
parameters. Consistent with previous research, individuals who maintained abstinence during the 
given time period (i.e., did not report an early lapse or early relapse) or withdrew from the study 
before having lapsed/relapsed were censored (e.g., al’Absi, Nakajima, Allen, Lemieux, & 
Hatsukami, 2015). Established procedures for the Cox proportional hazards model indicate that a 
minimum of 5 events should be included per predictor variable to increase confidence interval 
coverage, and decrease relative bias and type I error (Vittinghoff & McCulloch, 2007). After 
ensuring that our models were consistent with this recommendation (our models included 5 
predictor variables, and we observed 44 events for early lapse and 34 events for early relapse), 
covariates (i.e., ASI-3 total scores, past four-week pain severity, presence of current Axis I 
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psychopathology, and HSI scores) were entered into the first step of each model, and continuous 
PASS-20 scores were entered at the second step.  
           We used Kaplan Meier survival curves to compare the trajectories to early lapse and 
relapse between participants with high vs. low levels of pain-related anxiety. Consistent with 
previous research, PASS-20 scores were dichotomized via median split (e.g., Evans et al., 2013). 
The Kaplan Meier survival curve represents the probability of maintaining smoking abstinence 
for a given length of time while considering time in many small intervals (Goel, Khanna, & 
Kishore, 2010; Kaplan & Meier, 1958). Two survival curves can be compared statistically using 
a log-rank test to challenge the null hypothesis that the survival curves do not differ by group 
(Goel et al., 2010). If a significant log-rank result is observed (p < .05), then it can be concluded 
that the trajectory to lapse/relapse differs based on group status. These procedures are well-
established and have been used in numerous studies examining differences in time to 
lapse/relapse to cigarette smoking (e.g., López-Torrecillas, Rueda, López-Quirantes, Santiago, & 
Tapioles, 2014; Walker et al., 2011; Wong, Chan, & Lam, 2015).  
Results            
Participant Characteristics 
            Participants included 55 current daily tobacco smokers (66% male; Mage = 34.8, SD = 
14.6), who reported smoking approximately 16 cigarettes per day (SD = 5.5) for an average of 16 
years (SD = 14.0). The mean HSI score was 2.6 (SD = 1.4), indicating a moderate level of 
tobacco dependence (e.g., Chaiton, Cohen, McDonald, & Bondy, 2007). The sample was 
predominantly white (87%) and fairly well-educated (27% completed four years of college). 
Structured clinical interviews (SCID-IV-N/P) revealed that 38% of the sample met criteria for 
current (past month) Axis I psychopathology. PASS-20 total scores ranged from 0 to 68 (M = 
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28.4, SD = 16.5, median = 28.0). The majority of participants (n = 44; 80%) endorsed an early 
lapse to smoking, and about 62% of the sample (n = 34) endorsed an early relapse to smoking. 
We observed a moderate correlation (r = .543) between early lapse and early relapse, which 
indicates that although there was some overlap between early lapsers and early relapsers, these 
outcomes were not redundant (e.g., 25% of participants who endorsed an early lapse to smoking 
did not subsequently endorse an early relapse). Approximately 73% (n = 40) of the sample 
endorsed at least very mild past four-week pain, and smokers who endorsed past four-week pain 
reported higher levels of pain-related anxiety (M = 31.68, SD = 16.06) than those who did not 
endorse past four-week pain (M = 19.60, SD = 14.68; F [1, 53] = 6.449, p = .014). Among 
smokers who reported past four-week pain, 82.5% (n = 33) endorsed an early lapse to smoking, 
and 65% (n = 26) endorsed an early relapse. Sociodemographic and clinical data are presented in 
Table 1. 
Bivariate Correlations 
  PASS-20 total scores were positively correlated with past four-week pain severity (r = 
.37, p < .01), ASI-3 total scores (r = .70, p < .01), and the presence of current Axis I 
psychopathology (r = .30, p < .05). The presence of current Axis I psychopathology was 
negatively associated with number of days to first smoking lapse (r = -.29; p < .05). No 
additional covariates were identified via bivariate analyses (see Table 2). 
Pain-Related Anxiety and Early Lapse and Early Relapse to Smoking            
          As hypothesized, Cox regression analysis revealed that pain-related anxiety was a 
significant predictor of early smoking lapse (HR = 1.037, p = .013; see Table 3). Examination of 
the hazard ratio revealed that for every one point increase on the PASS-20, the risk of early lapse 
increased by 3.7%. These effects were evident above and beyond the variance accounted for by 
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tobacco dependence scores, past four-week pain severity, anxiety sensitivity, and the presence of 
current Axis I psychopathology. Also as hypothesized, Cox regression analysis revealed that 
pain-related anxiety was a significant predictor of early smoking relapse after accounting for the 
same covariates, such that for every one point increase on the PASS-20, the risk of early relapse 
increased by 3.6% (HR = 1.036, p = .027; see Table 4).  
Pain-Related Anxiety and Trajectories to Early Lapse and Early Relapse to Smoking  
Kaplan Meier survival analysis further revealed that, among early-lapsers, greater pain-
related anxiety predicted a more rapid trajectory to lapse (p = .037; Figure 3). All participants 
(100%) high in pain-related anxiety lapsed by day 7, compared to just 77.3% of those low in 
pain-related anxiety. Among early-relapsers, 84.2% of participants who reported high pain-
related anxiety relapsed by day 7, compared to only 66.7% of those low in pain-related anxiety. 
However, no significant differences in relapse trajectories were observed as a function of pain-
related anxiety (p = .322; Figure 4). 
Pain-Related Anxiety and Early Lapse/Relapse among Smokers with Pain 
To further explore relations between pain-related anxiety and early lapse/relapse, we 
replicated our analyses among the subsample of participants who endorsed past four-week pain. 
Similar to the primary findings, Cox regression analysis revealed that pain-related anxiety was a 
significant predictor of early smoking lapse among smokers who endorsed past four-week pain 
(HR = 1.050, p = .009; shown in Table 5), such that every one point increase on the PASS-20 
was associated with a 5.0% increase in the risk of early lapse. Although 78.3% of smokers with 
high levels of pain-related anxiety endorsed an early relapse to smoking (vs. 47.1% of smokers 
with low levels of pain-related anxiety), pain-related anxiety was not found to be a significant 
predictor of early relapse among smokers with past four-week pain (HR = 1.036, p = .075; see 
13 
 
 
 
Table 6). Kaplan Meier survival analyses revealed no differences in trajectory to lapse among 
early-lapsers (p = .098) or to relapse among early-relapsers (p = .958) as a function of pain-
related anxiety among participants with co-occurring pain.  
Discussion 
The current study is the first to examine pain-related anxiety as a predictor of lapse and 
relapse to smoking. As hypothesized, pain-related anxiety was observed to be a significant 
predictor of both early lapse and early relapse among a sample of smokers who were recruited 
from the local community to participate in a self-guided quit attempt. Importantly, these effects 
were evident above and beyond the variance accounted for by tobacco dependence, past four-
week pain severity, anxiety sensitivity, and the presence of current Axis I psychopathology. 
Among early-lapsers, greater pain-related anxiety was also associated with a more rapid 
trajectory to lapse. Pain and anxiety have both been shown to motivate smoking behavior, and it 
is possible that these factors may be more likely to interfere with quit attempts among smokers 
who endorse higher levels of pain-related anxiety (e.g., Ditre & Brandon, 2008; Ditre et al., 
2010; Kimbrel, Morissette, Gulliver, Langdon, & Zvolensky, 2014). Only recently have 
researchers begun to evaluate pain and anxiety-related cognitive-affective processes as potential 
mechanisms in the maintenance of tobacco dependence (e.g., Ditre et al., 2011a; Hooten, Shi, 
Gazelka, & Warner, 2011), and these findings are consistent with demonstrated positive 
associations between pain-related anxiety, smoking dependence motives (Ditre, Langdon, et al., 
2015; Ditre et al., 2013), and perceived barriers to cessation (Ditre, Langdon, et al., 2015). 
 Analyses conducted among the subsample of participants who endorsed past four-week 
pain largely corroborated the primary findings, and suggest that pain-related anxiety may be 
associated with an even greater risk of early lapse among smokers with co-occurring pain (every 
14 
 
 
 
one-point increase on the PASS-20 was associated with a 5% increased risk in early lapse among 
smokers with co-occurring pain, compared to a 3.7% increased risk among the total sample). 
Pain-related anxiety was not associated with risk of early relapse when analyses were limited to 
smokers who endorsed past four-week pain, though this may have been a function of reduced 
statistical power (n = 40). Interestingly, we observed a wide range of PASS-20 scores among the 
subsample of smokers who reported no past four-week pain (M = 19.60, SD = 14.68, range = 
55), demonstrating that smokers may endorse varying levels of pain-related anxiety, even in the 
absence of co-occurring pain.  
 Strengths of the current study include the prospective design and recruitment of daily 
tobacco smokers from the local community (such that the sample was not limited to persons with 
co-occurring pain). The utilization of diagnostic clinical interviews and in-person timeline 
follow-back assessments are additional methodological strengths. Finally, in examining early 
lapse/relapse outcomes, we were able to account for variance associated with tobacco 
dependence, past four-week pain severity, anxiety sensitivity, and the presence of current Axis I 
psychopathology. 
 Several limitations should also be noted, including the modest sample size. Although it is 
important that future work replicate these findings among a larger and more diverse sample of 
tobacco smokers, it can be beneficial to study smaller samples during the early stages of 
hypothesis testing (e.g., reduces time and cost, helps generate initial effect estimates), and we 
took steps to ensure that the Cox proportional hazards models were adequately powered. It is 
also important to consider that participants in this study volunteered to engage a self-guided quit 
attempt. Although an unaided quit approach confers several benefits (e.g., provides knowledge 
about self-quitters, prevents interpretive problems related to delivering an intervention, provides 
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a natural history of smoking cessation that can yield normative data against which treatment 
outcomes can be compared; e.g., Marlatt, Curry, & Gordon, 1988; Zvolensky et al., 2008), the 
extent to which these results may generalize to smokers receiving cessation treatment remains 
unclear. Finally, although duration of abstinence prior to first lapse and relapse has been shown 
to predict longer-term cessation outcomes (e.g., Brown et al., 2001; Garvey et al., 1992; Gilpin et 
al., 1997), this period of assessment does not adequately capture the dynamic process of quitting 
(e.g., Velicer, Prochaska, Rossi, & Snow, 1992). Future work should examine pain-related 
anxiety as a predictor of both prolonged and point prevalence cessation outcomes to better 
account for smokers who regain abstinence following an early lapse or relapse (e.g., Hughes et 
al., 2003; Velicer et al., 1992). 
 Clinical research has implicated pain-related anxiety in the onset and exacerbation of pain 
(e.g., Boersma & Linton, 2006), and these data contribute to an emerging literature which 
suggests that pain-related anxiety may also play a role in the maintenance of cigarette smoking. 
Thus, pain-related anxiety may warrant consideration as a transdiagnostic factor in the co-
occurrence of pain and tobacco addiction. Pain-related anxiety can be reduced via cognitive 
behavioral intervention (e.g., Lami et al., 2016; Watt, Stewart, Lefaivre, & Uman, 2006), and 
treatments for smokers with and without co-occurring pain may benefit from addressing pain-
related anxiety prior to smoking cessation. 
 In summary, results of the current study represent an initial, yet important step towards 
better understanding the role of pain-related anxiety in the maintenance of tobacco dependence. 
No previous research has examined associations between pain-related anxiety and attempts to 
abstain from smoking, and these findings provide the first evidence that high levels of pain-
related anxiety may be associated with early lapse and relapse to smoking tobacco cigarettes. 
16 
 
 
 
This and future work has the potential to inform the development of tailored cessation 
interventions for smokers who experience varying levels of pain intensity and pain-related 
anxiety. 
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Footnotes 
 1 Among participants who were eligible to participate in the quit attempt and completed 
the PASS-20, those who attended their quit day appointment smoked fewer cigarettes per day (M 
= 15.564, SD = 0.809) than those who did not attend their quit day appointment (M = 18.600, SD 
= 1.200), F (1, 78) = 4.399, p = .039. No differences in any other baseline sociodemographic, 
smoking, or pain variable were observed as a function of quit day attendance (all ps > .05). 
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Table 1 
 
Sociodemographic, smoking, and pain characteristics  
 
  
Total  
Sample 
 
Pain-Related Anxiety 
 
Past Four-Week Pain Status 
Low High No Pain Pain 
 n (%) n (%) n (%) n (%) n (%) 
Gender      
   Male 36 (65.5%) 22 (78.6%) 14 (51.9%) 9 (60.0%) 27 (67.5%) 
Race      
   White 48 (87.3%) 25 (89.3%) 23 (85.2%) 14 (93.3%) 34 (85.0%) 
   Black 3 (5.5%) 0 (0.0%) 3 (11.1%) 0 (0.0%) 3 (7.5%) 
   Other 4 (7.3%) 3 (10.7%) 1 (3.7%) 1 (6.7%) 3 (7.5%) 
Marital Status      
   Single 30 (54.5%) 13 (46.4%) 17 (63.0%) 9 (60.0%) 21 (52.5%) 
   Married/Living with Someone 15 (27.3%) 10 (35.7%) 5 (18.5%) 3 (20.0%) 12 (30.0%) 
   Separated/Divorced/Annulled 10 (18.2%) 5 (17.9%) 5 (18.5%) 3 (20.0%) 7 (17.5%) 
Education      
   12 Years 6 (10.9%) 2 (7.1%) 4 (14.8%) 2 (13.3%) 4 (10.0%) 
   12 - 15 Years 33 (61.9%) 20 (71.4%) 14 (51.8%) 9 (60.0%) 25 (62.5%) 
   ≥ 16 Years 15 (27.3%) 6 (21.4%) 9 (33.3%) 4 (26.7%) 11 (27.5%) 
Current Axis I Psychopathology a  21 (38.2%) 8 (28.6%) 13 (48.1%) 5 (33.3%) 16 (40.0%) 
Past Four-Week Pain Severity b      
   None 15 (27.3%) 11 (39.3%) 4 (14.8%) 15 (100%) 0 (0.0%) 
   Very Mild 22 (40.0%) 10 (35.7%) 12 (44.4%) 0 (0.0%) 22 (55.0%) 
   Mild 9 (16.4%) 4 (14.3%) 5 (18.5%) 0 (0.0%) 9 (22.5%) 
   Moderate 6 (10.9%) 1 (3.6%) 5 (18.5%) 0 (0.0%) 6 (15.0%) 
   Severe 3 (5.5%) 2 (7.1%) 1 (3.7%) 0 (0.0%) 3 (7.5%) 
      
 M (SD) M (SD) M (SD) M (SD) M (SD) 
      
Age 34.78 (14.55) 34.46 (15.58) 35.11 (13.68) 29.87 (12.64) 36.63 (14.93) 
Cigarettes per Day 15.56 (5.53) 16.32 (6.40) 14.78 (4.45) 16.27 (6.87) 15.30 (5.01) 
Years of Smoking 16.25 (13.98) 15.75 (14.72) 16.78 (13.44) 12.80 (13.68) 17.55 (14.04) 
Tobacco Dependence c 2.56 (1.40) 2.75 (1.48) 2.37 (1.31) 2.73 (1.44) 2.50 (1.40) 
Anxiety Sensitivity d1 14.82 (12.44) 8.61 (6.15) 21.26 (14.05) 11.47 (8.53) 16.08 (13.50) 
Pain-Related Anxiety e12 28.38 (16.48) 15.71 (8.16) 41.52 (11.95) 19.60 (14.68) 31.68 (16.06) 
Days to First Lapse 12.92 (26.67) 18.48 (31.86) 6.92 (18.42) 17.14 (29.04) 11.37 (25.98) 
Days to First Relapse 21.65 (31.29) 28.18 (35.91) 15.66 (25.69) 27.55 (33.49) 19.80 (30.84) 
 
Note. a Structured Clinical Interview for DSM-IV Non-Patient Edition (SCID-IV-N/P); b Short 
Form Health Survey – 12; c Heaviness of Smoking Index; d Anxiety Sensitivity Index – III; e Pain 
Anxiety Symptoms Scale – 20 item. 1Significant (p < .05) difference as a function of pain-related 
anxiety; 2Significant (p < .05) difference as a function of past four-week pain status 
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Table 2 
 
Bivariate correlations between variables of primary interest 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1 Age - -.11 .01 .22 -.53** .26 .01 -.12 .38** -.09 .03 .14 
2 Gender  - .08 -.12 -.06 -.13 .18 -.02 -.07 -.20 -.06 .21 
3 Race   - .05 .00 -.06 .00 -.21 .06 -.14 -.16 .06 
4 Education Level    - -.06 -.09 -.09 -.10 .07 .00 -.16 .11 
5 Marital Status     - .01 -.00 .18 -.21 .07 .09 .02 
6 Tobacco Dependence a      - -.09 -.05 -.05 -.16 .21 -.12 
7 Anxiety Sensitivity b       - .41** .35** -.06 .03 .70** 
8 Current Axis I Psychopathology c        - .14 .21 .16 .30* 
9 Past Four-Week Pain Severity d         - .20 -.01 .37** 
10 Early Lapse           - .54** -.17 
11 Early Relapse            - .17 
12 Pain-Related Anxiety e            - 
 
Note. Gender: 0 = female, 1 = male. a Heaviness of Smoking Index; b Anxiety Sensitivity Index – 
III; c Structured Clinical Interview for DSM-IV Non-Patient Edition (SCID-IV-N/P); d Short Form 
Health Survey – 12; e Pain Anxiety Symptoms Scale – 20; * p < .05; ** p < .01 
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Table 3 
 
Cox Proportional Hazards Regressions 
 
 Unadjusted Hazard 
Ratio 95% 
Confidence Interval 
 
 
   p 
Adjusted Hazard 
Ratio 95% 
Confidence Interval 
 
 
   p 
Early Lapse among Entire Sample a     
   Past Four-Week Pain Severity c 1.160 (.915-1.469) .219 1.172 (.901-1.525) .238 
   Anxiety Sensitivity d .999 (.976-1.022) .938 .940 (.899-.982) .005** 
   Current Axis I Psychopathology e 2.232 (1.183-4.210) .013* 3.567 (1.641-7.755) .001** 
   Tobacco Dependence f .988 (.815-1.197) .900 1.129 (.897-1.421) .302 
   Pain-Related Anxiety g 1.011 (.995-1.028) .174 1.037 (1.008-1.068) .013* 
Early Relapse among Entire Sample b     
   Past Four-Week Pain Severity  1.066 (.804-1.412) .658 1.041 (.748-1.449) .812 
   Anxiety Sensitivity  1.007 (.981-1.033) .597 .958 (.913-1.004) .071 
   Current Axis I Psychopathology  1.895 (.947-3.789) .071 3.033 (1.276-7.207) .012* 
   Tobacco Dependence  1.175 (.926-1.492) .185 1.379 (1.032-1.842)                   .030*
   Pain-Related Anxiety  1.014 (.995-1.033)            .154 1.036 (1.004-1.069)                   .027*
Early Lapse among Participants with Pain      
   Past Four-Week Pain Severity  1.043 (.748-1.453) .804 .993 (.687-1.434) .968 
   Anxiety Sensitivity  1.007 (.986-1.029) .517 .944 (.898-.992) .023* 
   Current Axis I Psychopathology  1.863 (.896-3.876) .096 2.767 (.977-7.833) .055 
   Tobacco Dependence  .965 (.772-1.205) .752 1.055 (.820-1.357) .677 
   Pain-Related Anxiety  1.019 (1.000-1.039) .046* 1.050 (1.012-1.089) .009** 
Early Relapse among Participants with Pain     
   Past Four-Week Pain Severity b .884 (.583-1.340) .562 .862 (.549-1.352) .517 
   Anxiety Sensitivity c 1.010 (.985-1.036) .443 .966 (.914-1.021) .216 
   Current Axis I Psychopathology d 1.816 (.825-3.995) .138 2.443 (.818-7.292) .109 
   Tobacco Dependence e 1.141 (.866-1.503) .350 1.234 (.910-1.673)                   .176
   Pain-Related Anxiety f 1.017 (.995-1.040)            .122 1.036 (.996-1.078)                   .075
 
Note. a First lapse within 14 days; b relapse within 28 days;  c Short Form Health Survey – 12; d 
Anxiety Sensitivity Index – III; e Structured Clinical Interview for DSM-IV Non-Patient Edition 
(SCID-IV-N/P); f Heaviness of Smoking Index; g Pain Anxiety Symptoms Scale – 20;  
* p < .05; ** p < .01.  
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Figure 1. Inclusion of participants in the current study. a Pain Anxiety Symptoms Scale – 20 
item. 
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smoking study 
(n = 122) 
Ineligible following baseline 
(n = 39) 
 
-Psychotropic medications (n = 3) 
-Exhaled CO < 8ppm (n = 16) 
- Substance Dependence (n = 18) 
-CPD reduction > 50% in last 6 
months (n = 1) 
-Other (n = 1) 
 
 
 
 
Did not complete  
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(n = 3) 
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attempt and 
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20a 
(n = 80) 
 
Attended quit day 
appointment and 
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analyses 
(n = 55) 
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Figure 2. Study procedure. a Pain Anxiety Symptoms Scale – 20 item; b Anxiety Sensitivity 
Index – III; c Heaviness of Smoking Index; d Structured Clinical Interview for DSM-IV Non-
Patient Edition (SCID-IV-N/P); e Timeline Follow Back Procedures.  
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Figure 3. Kaplan-Meier survival curves to first smoking lapse among early-lapsers. 
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Figure 4. Kaplan-Meier survival curves to first smoking relapse among early-relapsers. 
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Appendix A 
 
Pain-Anxiety Symptoms Scale (PASS-20) 
 
INSTRUCTIONS: Individuals who experience pain develop different ways to respond to that 
pain. We would like to know what you do or what you think about when in pain. Please use the 
rating scale below to indicate how often you engage in each of the following thoughts or 
activities. Record your rating on the line next to each item. 
Never           Always 
0 1 2 3 4 5 
 
______1.  I think that if my pain gets too severe, it will never decrease. 
______2.  When I feel pain, I am afraid that something terrible will happen. 
______3.  I go immediately to bed when I feel severe pain. 
______4. I begin trembling when engaged in an activity that increases pain. 
______5. I can’t think straight when in pain. 
______6. I will stop any activity as soon as I sense pain is coming on. 
______7. Pain seems to cause my heart to pound or race.  
______8. As soon as pain comes on I take medication to reduce it. 
______9. When I feel pain, I think that I might be seriously ill. 
______10. During painful episodes it is difficult for me to think of anything besides the pain. 
______11. I avoid important activities when I hurt. 
______12. When I sense pain, I feel dizzy or faint. 
______13. Pain sensations are terrifying. 
______14. When I hurt, I think about the pain constantly. 
______15. Pain makes me nauseous. 
______ 16. When pain comes on strong I think that I might become paralyzed or more disabled. 
______17. I find it hard to concentrate when I hurt. 
______18. I find it difficult to calm my body down after periods of pain. 
______19. I worry when I am in pain. 
______20. I try to avoid activities that cause pain. 
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Appendix B 
 
Past Four-Week Pain Severity 
 
How much bodily pain have you had during the past 4 weeks? (circle one) 
 
None Very Mild Mild Moderate Severe 
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Appendix C 
 
Heaviness of Smoking Index (HSI) 
 
1. How soon after you wake up do you smoke your first cigarette? 
 Within 5 minutes 
 6 - 30 minutes 
 31 - 60 minutes 
 After 60 minutes 
2. How many cigarettes per day do you smoke? 
 10 or less 
 11 - 20 
 21 - 30 
 31 or more 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28 
 
 
 
Appendix D 
 
Timeline Follow-Back for Cigarette Use 
 
Instructions for Filling Out the Timeline Cigarette Use Calendar 
To help us evaluate your cigarette use, we need to get an idea of what your smoking was 
like in the past ____ days. To do this, we would like you to fill out the attached calendar.  
 Filling out the calendar is not hard! 
 Try to be as accurate as possible. 
 We recognize you won’t have perfect recall. That’s OKAY. 
 
 WHAT TO FILL IN 
• The idea is to record how many cigarettes you smoked for each day on the calendar. 
• On days when you did not smoke cigarettes, not even one, you should write a “0.”  
It’s important that something is written for every day, even if it is a “0”. 
 
 YOUR BEST ESTIMATE  
• We realize it isn’t easy to recall things with 100% accuracy.  
• If you are not sure whether you smoked 15 or 16 cigarettes or whether you smoked on 
a Thursday or a Friday, give it your best guess! What is important is that 15 or 16 
cigarettes is very different from 1 cigarette. The goal is to get a sense of how 
frequently you smoked, how much you smoked, and your patterns of smoking. 
 
 HELPFUL HINTS 
• If you have an appointment book you can use it to help you recall your use. 
• Holidays such as Thanksgiving and Christmas are marked on the calendar to help you 
recall your smoking. Also, think about how much you smoked on personal holidays & 
events such as birthdays, vacations, or parties.  
• If you have regular patterns to your smoking, you can use these to help you recall 
your use. For example, some people may only smoke during social situations. 
 
 COMPLETING THE CALENDAR 
• A blank calendar is attached. Write in the number of cigarettes you smoked on each 
day. 
• The time period we are talking about on the calendar is  
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 from ________________________ to _______________________. 
• In estimating the number of cigarettes you smoked, be as accurate as possible. 
• DOUBLE CHECK THAT ALL DAYS ARE FILLED IN BEFORE RETURNING THE 
CALENDAR.  
• Before you start look at the SAMPLE CALENDAR.  
 
 SAMPLE CALENDAR 
 
 
2000 SUN MON TUES WED THURS FRI SAT 
 
     
1 
20 
2 
0 
S 3 
20 
4
 Labor Day 
20 
5 
23 
6 
28 
7 
21 
8 
20 
9 
23 
E 10 
20 
11 
20 
12 
20 
13 
28 
14 
25 
15 
0 
16 
24 
P 17 
20 
18 
20 
19 
20 
20 
20 
21 
22 
22 
22 
23 
24 
T 
24 
21 
25
 
22 
26 
26 
27 
24 
28 
23 
29 
0 
30 
22 
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Appendix E 
 
Anxiety Sensitivity Index – III (ASI-3) 
 
Please select the number that best corresponds to how much you agree with each item. If any 
items concern something that you have never experienced (e.g. fainting in public) answer on the 
basis of how you think you might feel if you had such an experience. Otherwise, answer all items 
on the basis of your own experience. Be careful to select only one number for each item and 
please answer all items. 
 
Very 
little 
0 
 
A 
little 
1 
 
Some 
2 
 
Much 
3 
Very 
Much 
4 
1. It is important for me not to appear nervous.           
2. When I cannot keep my mind on task I worry I 
might be going crazy. 
          
3. It scares me when my heart beats rapidly.           
4. When my stomach is upset, I worry I may be 
seriously ill. 
          
5. It scares me when I am unable to keep my 
mind on a task. 
          
6. When I tremble in the presence of others, I fear 
what people might think of me. 
          
7. When my chest feels tight, I get scared that I 
won't be able to breathe properly. 
          
8. When I feel pain in my chest, I worry that I'm 
going to have a heart attack. 
          
9. I worry that other people will notice my 
anxiety. 
          
10. When I feel "spacey" or spaced out I worry I 
may be mentally ill. 
          
11. It scares me when I blush in front of people.           
12. When I notice my heart skipping a beat, I 
worry that there is something seriously wrong 
with me. 
          
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13. When I begin to sweat in a social situation, I fear 
people will think negatively of me. 
          
14. When my thoughts seem to speed up, I worry that 
I might be going crazy. 
          
15. When my throat feels tight, I worry that I could 
choke to death. 
          
16. When I have trouble thinking clearly, I worry that 
there is something wrong with me. 
          
17. I think it would be horrible for me to faint in 
public. 
          
18. When my mind goes blank, I worry there is 
something terribly wrong with me. 
          
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